What amount sold does Larx Fund 1, LP report in Form D filings?

The latest linked filings report $4.3M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Larx Fund 1, LP's most recent SEC filing?

Larx Fund 1, LP's most recent Form D filing was on 2023-04-04.

How many investors does Larx Fund 1, LP have?

The most recent Form D filing lists 15 investor(s).

Larx Fund 1, LP

CIK: 0001646694·Pooled Investment Fund·SAN JUAN, PR·Limited Partnership

Reported Sold

$4,326,850

Total Filings

Identified Offerings

Last Filed

Apr 4, 2023

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Apr 4, 2023Form D/A — Amendment

Reported sold: $4,326,850 · Target: Indefinite

Rule 506(b)·15 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Apr 11, 2022Form D/A — Amendment

Reported sold: $3,215,364 · Target: Indefinite

Rule 506(b)·16 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jan 30, 2018Form D/A — Amendment

Reported sold: $2,699,364 · Target: Indefinite

Rule 506(b)·9 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jan 27, 2016Form D/A — Amendment

Reported sold: $2,289,989 · Target: Indefinite

Rule 506(b)·7 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jul 1, 2015Form D — New notice

Reported sold: $597,000 · Target: Indefinite

Rule 506(b)·5 investors·Section 3(c), Section 3(c)(1)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

80%

Latest reported sold across 1 identified offering

$4,326,850

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Brandon Spruill

Related Person

Appears on 4 filings

Larx Capital, LLC

Related Person

Appears on 4 filings

Brandon Spruill

Related Person

Appears on 1 filing

Larx Capital, LLC

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 4, 2023	Amendment	Indefinite	$4,326,850	15
Apr 11, 2022	Amendment	Indefinite	$3,215,364	16
Jan 30, 2018	Amendment	Indefinite	$2,699,364	9
Jan 27, 2016	Amendment	Indefinite	$2,289,989	7
Jul 1, 2015	New	Indefinite	$597,000	5

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Convex Venture Fund, LP - Series 11

Pooled Investment Fund

Offering target: Indefinite

Filed Oct 30, 2026